Wednesday, July 8, 2026

pharma · Endometrial cancer · Specific Advanced Solid Tumors · ACRV

Acrivon Therapeutics

News and analysis for Acrivon Therapeutics on NovaPharmaNews — regulatory, clinical, and market coverage.

Cambridge, USA HQ
2018 Founded
84 Employees
Public company Type
ACRV · NYSE Ticker
Company details
Status
Public
HQ
Cambridge, USA
Founded
2018
Employees
84
Programs
4
Drugs
3
Patents
0
Intelligence · Coverage

News & analysis

NovaPharmaNews articles mentioning Acrivon Therapeutics — regulatory, clinical, and market coverage.

News and analysis for Acrivon Therapeutics on NovaPharmaNews — regulatory, clinical, and market coverage.

No coverage yet

We have not published news or analysis mentioning Acrivon Therapeutics yet.

Back to company overview →